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Abstract The interesting data reported by Bern-
hardt et al. strengthen the diagnostic beneﬁt of CMR
in patients with ischemic cardiomyopathy. Conse-
quently, the presence, location and size of the CMR-
determined scar tissue may be used for better risk
stratiﬁcation in patients with ischemic cardiomyopa-
thy eligible for ICD therapy.
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Over the past years considerable progress has been
made in the ﬁeld of cardiovascular magnetic reso-
nance (CMR), providing accurate evaluation of left
ventricular function particularly in patients prone to
heart failure due to both ischemic and non-ischemic
cardiomyopathy [1–14]. In particular, high-resolution
contrast-enhanced CMR has been used to visualize
myocardial ﬁbrosis with a high accuracy [15–22]. For
instance, in patients with acute myocardial infarction,
the injured myocardium shows increased CMR
contrast compared to normal myocardium when
imaged by delayed gadolinium enhancement. The
transmural extent of delayed gadolinium enhance-
ment predicts functional outcome after interventional
procedures performed in patients with acute myocar-
dial infarction and chronic ischemic heart disease
[23–32]. Not only in the setting of an acute myocar-
dial infarction, but also in patients with various
manifestations of cardiomyopathy, evidence of
delayed gadolinium enhancement may have impor-
tant clinical and prognostic implications [32–36]. In
patients eligible for cardiac resynchronization ther-
apy, the presence of scar tissue may have conse-
quences for implanting a biventricular device and
subsequent accurate lead positioning [37–51]. In
patients with hypertrophic cardiomyopathy, the pres-
ence of ﬁbrotic tissue may result in increased
occurrence of ventricular arrhythmias [52–57].
Recently, it has been shown that presence and
quantity of late enhancement is correlated with
cardiovascular events and arrhythmias in patients
with dilated cardiomyopathy [58–61].
In the present issue of the International Journal of
Cardiovascular Imaging, Bernhardt et al. [62] address
the hypothesis that infarct size in patients with
ischemic cardiomyopathy is related to spontaneous
monomorphic ventricular tachycardia which may be
determined by contrast-enhanced CMR. The purpose
of the study was to establish the relationship between
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spontaneous ventricular tachy-arrhythmias in patients
with ischemic cardiomyopathy who underwent
implantable cardioverter-deﬁbrillator (ICD) therapy.
A total of 41 patients with ischemic cardiomyopathy
and an indication for ICD therapy underwent delayed
gadolinium enhancement CMR for quantiﬁcation of
left ventricular volumes, function and myocardial scar
tissue before subsequent implantation of an ICD
device. During a follow-up period of 1,184 ±
442 days 68 monomorphic and 14 polymorphic types
of ventricular tachycardia could be observed in 12
patients. Patients with monomorphic ventricular
tachycardia had more extensive scar tissue than
patients with polymorphic ventricular tachycardia
(mean 25% vs. mean 12% of myocardial mass).
Moreover, myocardial infarction involved more seg-
ments in the region of the left anterior descending
coronary artery (LAD) than in patients with polymor-
phic ventricular tachycardia (86 vs. 20%). During the
long-term follow-up period, patients with spontaneous
monomorphic ventricular tachycardia had more
infarcted tissue, being more often present in the
LAD region, than patients with polymorphic events.
As a result, the most important ﬁnding of the study
was a signiﬁcant difference between patients with
monomorphic and polymorphic events. Patients with
monomorphic ventricular arrhythmias during follow
up had more dilated ventricles, decreased ejection
fractions and larger scar volumes than patients with
polymorphic events. More segments in the LAD
region showed scar patterns in patients with mono-
morphic events. This larger extent of scar tissue in the
LAD region was independent of the indication for
ICD implantation compared to patients with poly-
morphic ventricular arrhythmias.
Several studies have recently focused on the
relation between the extent of myocardial scar tissue
and the incidence of ventricular arrhythmias in
patients with ischemic cardiomyopathy. Fernandes
et al. [63] determined whether mechanical behavior
of left ventricular wall segments containing different
degrees of scar tissue and localized at different
distances from the interface between infarcted and
noninfarcted myocardial tissue could assist in pre-
dicting inducibility of monomorphic ventricular
tachycardia in 46 patients with ischemic cardiomy-
opathy. They showed that inducible patients had
more infarcted and border zone sectors and a shorter
time to peak circumferential shortening strain than
did noninducible patients in the border zone of
adjacent and infarcted regions. Yokokawa et al. [64]
sought to clarify the relationship between the scar
characteristics and occurrence of sustained ventricu-
lar tachycardias in 47 patients with advanced heart
failure. The volume of the hyperenhanced areas and
total number of hyperenhanced segments were
greater in patients with sustained ventricular tachy-
cardias than in those without. The presence and
magnitude of the nontransmural scar tissue predicted
sustained ventricular tachycardias in patients with
advanced heart failure. Di Bella et al. [65] investi-
gated the relationship between nonsustained ventric-
ular tachycardia and left ventricular dilatation,
function, remodeling, and CMR-assessed scar tissue
extent in patients with previous myocardial infarc-
tion. It was shown that necrotic and viable myocar-
dium coexistence within the same wall segments
predicted occurrence of nonsustained ventricular
tachycardia in patients without left ventricular dila-
tation, whereas left ventricular mass and end-systolic
volume were predictors of nonsustained ventricular
tachycardia in those with left ventricular dilatation.
Roes et al. [66] recently studied 91 patients with
ischemic cardiomyopathy for a mean duration of
8.5 months after ICD implantation for ICD therapy in
spontaneous ventricular tachycardias. The authors
showed that patients with appropriate ICD therapy
had larger myocardial scar detected by CMR than
patients without appropriate ICD therapy. They
concluded that infarct tissue heterogeneity on con-
trast-enhanced CMR was the strongest predictor of
spontaneous ventricular arrhythmia with subsequent
ICD therapy (as surrogate of sudden cardiac death)
among other clinical and CMR variables in patients
with previous myocardial infarction. However, the
authors did not distinguish between monomorphic
and polymorphic ventricular tachycardia, and rather
addressed ICD therapy itself.
Apart from the value of scar identiﬁcation in
patients with left ventricular dysfunction, delayed
gadolinium enhancement CMR can also be used to
assess the long-term arrhythmia recurrence rate and
outcome in patients with scar-related ventricular
tachycardia of right ventricular origin [67–69].
Wijnmaalen et al. [69] studied 29 (45%) patients
diagnosed with arrhythmogenic right ventricular
dysplasia according to Task Force criteria (TF?)
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123and 35 (55%) with right ventricular scar of undeter-
mined origin (TF-) at the end of follow-up (64 ±
42 months). The authors demonstrated that scar-
related right ventricular tachycardias have a high
recurrence rate in TF? and TF- patients. Patients
presenting with a fast index ventricular tachycardia
are at high risk for recurrence of fast ventricular
tachycardias and may beneﬁt most from ICD therapy.
To summarize, the interesting data reported by
Bernhardt et al. [62] strengthen the diagnostic beneﬁt
of using CMR in patients with ischemic cardiomy-
opathy. Consequently, the presence, location and size
of the CMR-determined scar tissue may be used for
better risk stratiﬁcation in patients with ischemic
cardiomyopathy eligible for ICD therapy.
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